TCL Archive Minority Accrual Low In Prevention Trials; NCI Plans Programs To Boost enrollment February 2, 1996
TCL Archive Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression November 30, 2012